Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Current Deferred Tax Assets: 2009-2015

Historic Current Deferred Tax Assets for Cumberland Pharmaceuticals (CPIX) over the last 1 years, with Dec 2015 value amounting to $2.5 million.

  • Cumberland Pharmaceuticals' Current Deferred Tax Assets fell 30.74% to $2.5 million in Q4 2015 from the same period last year, while for Dec 2015 it was $2.5 million, marking a year-over-year decrease of 30.74%. This contributed to the annual value of $2.5 million for FY2015, which is 30.74% down from last year.
  • Cumberland Pharmaceuticals' Current Deferred Tax Assets amounted to $2.5 million in Q4 2015, which was down 30.74% from $3.7 million recorded in Q4 2014.
  • Cumberland Pharmaceuticals' Current Deferred Tax Assets' 5-year high stood at $3.7 million during Q4 2014, with a 5-year trough of $2.2 million in Q4 2011.
  • For the 3-year period, Cumberland Pharmaceuticals' Current Deferred Tax Assets averaged around $3.0 million, with its median value being $2.7 million (2013).
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Current Deferred Tax Assets spiked by 127.21% in 2011 and then slumped by 30.74% in 2015.
  • Over the past 5 years, Cumberland Pharmaceuticals' Current Deferred Tax Assets (Quarterly) stood at $2.2 million in 2011, then grew by 2.98% to $2.3 million in 2012, then rose by 18.40% to $2.7 million in 2013, then spiked by 34.65% to $3.7 million in 2014, then slumped by 30.74% to $2.5 million in 2015.
  • Its last three reported values are $2.5 million in Q4 2015, $3.7 million for Q4 2014, and $2.7 million during Q4 2013.